Freestone Capital Holdings’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.6M | Sell |
65,869
-4,133
| -6% | -$889K | 0.43% | 37 |
|
|
2026
Q1 | $15.2M | Buy |
70,002
+788
| +1% | +$175K | 0.46% | 33 |
|
|
2025
Q4 | $15.8M | Sell |
69,214
-244
| -0.4% | -$55.6K | 0.47% | 38 |
|
|
2025
Q3 | $16.1M | Buy |
69,458
+1,915
| +3% | +$390K | 0.49% | 36 |
|
|
2025
Q2 | $12.5M | Sell |
67,543
-720
| -1% | -$134K | 0.42% | 40 |
|
|
2025
Q1 | $14.3M | Buy |
68,263
+2,567
| +4% | +$499K | 0.53% | 33 |
|
|
2024
Q4 | $11.7M | Buy |
65,696
+1,584
| +2% | +$291K | 0.4% | 47 |
|
|
2024
Q3 | $12.7M | Sell |
64,112
-2,160
| -3% | -$403K | 0.44% | 46 |
|
|
2024
Q2 | $11.4M | Sell |
66,272
-1,279
| -2% | -$212K | 0.41% | 48 |
|
|
2024
Q1 | $12.3M | Buy |
67,551
+4,059
| +6% | +$700K | 0.46% | 43 |
|
|
2023
Q4 | $9.84M | Buy |
63,492
+370
| +0.6% | +$53.9K | 0.44% | 46 |
|
|
2023
Q3 | $9.41M | Buy |
63,122
+2,593
| +4% | +$381K | 0.5% | 46 |
|
|
2023
Q2 | $8.16M | Sell |
60,529
-450
| -0.7% | -$66K | 0.33% | 58 |
|
|
2023
Q1 | $9.72M | Sell |
60,979
-35
| -0.1% | -$5.35K | 0.43% | 43 |
|
|
2022
Q4 | $9.86M | Sell |
61,014
-9,745
| -14% | -$1.49M | 0.45% | 38 |
|
|
2022
Q3 | $9.5M | Sell |
70,759
-7,884
| -10% | -$1.13M | 0.43% | 35 |
|
|
2022
Q2 | $12M | Sell |
78,643
-12,571
| -14% | -$1.92M | 0.46% | 31 |
|
|
2022
Q1 | $14.8M | Sell |
91,214
-4,816
| -5% | -$700K | 0.59% | 32 |
|
|
2021
Q4 | $13M | Buy |
96,030
+3,725
| +4% | +$440K | 0.55% | 40 |
|
|
2021
Q3 | $9.96M | Buy |
92,305
+10,157
| +12% | +$1.16M | 0.5% | 45 |
|
|
2021
Q2 | $9.25M | Buy |
82,148
+1,041
| +1% | +$117K | 0.46% | 49 |
|
|
2021
Q1 | $8.78M | Sell |
81,107
-2,276
| -3% | -$243K | 0.48% | 51 |
|
|
2020
Q4 | $8.93M | Buy |
83,383
+10,836
| +15% | +$1.04M | 0.52% | 39 |
|
|
2020
Q3 | $6.35M | Buy |
72,547
+929
| +1% | +$87.5K | 0.41% | 55 |
|
|
2020
Q2 | $7.03K | Buy |
71,618
+17,179
| +32% | +$1.51M | 0.08% | 53 |
|
|
2020
Q1 | $4.15K | Buy |
54,439
+7,542
| +16% | +$642K | 0.09% | 81 |
|
|
2019
Q4 | $4.15K | Sell |
46,897
-7,698
| -14% | -$639K | 0.09% | 97 |
|
|
2019
Q3 | $4.13K | Sell |
54,595
-5,982
| -10% | -$410K | 0.1% | 97 |
|
|
2019
Q2 | $4.41K | Sell |
60,577
-3,288
| -5% | -$258K | 0.11% | 111 |
|
|
2019
Q1 | $5.15M | Sell |
63,865
-33,865
| -35% | -$2.77M | 0.31% | 97 |
|
|
2018
Q4 | $9.01M | Sell |
97,730
-11,366
| -10% | -$1,000K | 0.61% | 42 |
|
|
2018
Q3 | $10.3M | Buy |
109,096
+7,498
| +7% | +$711K | 0.07% | 51 |
|
|
2018
Q2 | $9.41M | Buy |
101,598
+25,374
| +33% | +$2.48M | 0.06% | 58 |
|
|
2018
Q1 | $7.21M | Buy |
76,224
+298
| +0.4% | +$32.7K | 0.42% | 64 |
|
|
2017
Q4 | $7.34M | Buy |
75,926
+340
| +0.4% | +$32K | 0.51% | 54 |
|
|
2017
Q3 | $6.72M | Buy |
75,586
+3,910
| +5% | +$298K | 0.48% | 57 |
|
|
2017
Q2 | $5.2M | Buy |
71,676
+3,918
| +6% | +$263K | 0.4% | 57 |
|
|
2017
Q1 | $4.42M | Buy |
67,758
+7,384
| +12% | +$464K | 0.34% | 58 |
|
|
2016
Q4 | $3.78M | Buy |
60,374
+14,240
| +31% | +$869K | 0.32% | 66 |
|
|
2016
Q3 | $2.91M | Buy |
46,134
+5,983
| +15% | +$387K | 0.27% | 77 |
|
|
2016
Q2 | $2.49M | Buy |
40,151
+6,436
| +19% | +$392K | 0.24% | 78 |
|
|
2016
Q1 | $1.93M | Buy |
33,715
+11,250
| +50% | +$627K | 0.2% | 89 |
|
|
2015
Q4 | $1.33M | Buy |
22,465
+7,250
| +48% | +$418K | 0.14% | 120 |
|
|
2015
Q3 | $828K | Buy |
15,215
+6,450
| +74% | +$420K | 0.09% | 178 |
|
|
2015
Q2 | $589K | Buy |
8,765
+3,718
| +74% | +$243K | 0.09% | 158 |
|
|
2015
Q1 | $295K | Hold |
5,047
| – | – | 0.05% | 155 |
|
|
2014
Q4 | $330K | Hold |
5,047
| – | – | 0.05% | 150 |
|
|
2014
Q3 | $292K | Sell |
5,047
-300
| -6% | -$16.7K | 0.05% | 123 |
|
|
2014
Q2 | $302K | Sell |
5,347
-81
| -1% | -$4.25K | 0.05% | 161 |
|
|
2014
Q1 | $279K | Sell |
5,428
-1,021
| -16% | -$51.6K | 0.05% | 163 |
|
|
2013
Q4 | $341K | Buy |
6,449
+1,151
| +22% | +$56.6K | 0.06% | 226 |
|
|
2013
Q3 | $237K | Sell |
5,298
-24,674
| -82% | -$1.09M | 0.04% | 301 |
|
|
2013
Q2 | $1.24M | Buy |
+29,972
| New | +$1.31M | 0.25% | 58 |
|
Other funds holding ABBV
Freestone Capital Holdings's ABBV Position: Q2 2026 in Review
Freestone Capital Holdings reduced its AbbVie (ABBV) stake by 5.9% in Q2 2026, selling an estimated $889K and leaving 65,869 shares worth $16.6M. The position accounts for 0.43% of the portfolio, ranked #37.
Freestone Capital Holdings first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,190 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Freestone Capital Holdings held 65,869 shares of AbbVie worth $16.6M as of Q2 2026.
- Freestone Capital Holdings sold 4,133 AbbVie shares in Q2 2026, an estimated $889K.
- AbbVie made up 0.43% of Freestone Capital Holdings's portfolio in Q2 2026, its #37 holding.
- Freestone Capital Holdings first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 4,190 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Freestone Capital Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.